GUOYAO CHUANGXIN
Guoyao Chuangxin is an investment firm that provides asset management and investment management services.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-12-13 | JoyMed Technology | Guoyao Chuangxin investment in Seed Round - JoyMed Technology | 28 M CNY |
More informations about "Guoyao Chuangxin"
Guoyao Chuangxin - Investments, Portfolio & Company Exits
Dec 13, 2016 Guoyao Chuangxin is an investment firm that provides asset management and investment management services.See details»
JoyMed Technology - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Guoyao Chuangxin . No: …See details»
Clarium Capital — 7 Investments, Performance analytics, Stats — …
This organization was formed by Bill Calayag, Peter Thiel. Besides them, we counted 1 critical employee of this fund in our database. ... Guoyao Chuangxin: China, Shanghai: Jianpu …See details»
Sinopharm (company) - Wikipedia
39°58′29″N 116°20′24″E / 39.9747°N 116.3401°E China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (SEHK: 1099, via a 51–49 joint venture, Sinopharm Industrial Investme…See details»
Mr. Sun Haisheng, Secretary of Laoshan District Committee, and …
On January 27, 2021, Sun Haisheng, Secretary of the Laoshan District Committee of Qingdao City, Zhuang Jinjie, Member of the Standing Committee of the Laoshan District Committee and …See details»
Chinese Startup Wants to Replace Chemical Rocket with …
LONDON, Sept. 20, 2020 /PRNewswire/ -- On September 20, 2020, Guangzhou-based company Guoyao Tech announced a roadmap to complete a prototype launch of 10 kg by 2022 and …See details»
How China’s ‘technological independence’ strategy will transform …
Nov 27, 2020 ‘Indigenous innovation’ (zizhu chuangxin) has been a strategic emphasis for decades in China. Led by the state-owned sector, China’s indigenous innovation policy has …See details»
Guoyao Chuangxin - Crunchbase
Guoyao Chuangxin is an investment firm that provides asset management and investment management services.See details»
Chuangxin Guo | IEEE Xplore Author Details
A not-for-profit organization, IEEE is the world's largest technical professional organization dedicated to advancing technology for the benefit of humanity. ... Author Bio: Chuangxin Guo …See details»
Guoyao Chuangxin — 1 Investments, Performance analytics, Stats ...
Guoyao Chuangxin. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom list of …See details»
Implications of China's innovation policy shift: Does “indigenous” …
Jun 13, 2020 The alternatives of carrying out R&D in-house or sourcing R&D receive broad attention in the innovation and organization literature in general (Beneito, 2003; Narula, 2001), …See details»
Guo Chuangxin - Zhejiang University
[37] Bin Ye, Chuangxin Guo , et al, Short-term load forecasting using a new fuzzy modeling strategy, Proc. of World Congress on Intelligent Control and Automation, June, 2004, pp.5045 …See details»
The End of the CCP's Resilient Authoritarianism? A Tripartite ...
Oct 8, 2012 This essay challenges the widely held view of the CCP's purported “resilient authoritarianism,” which asserts that China's one-party political system is able to enhance the …See details»
Measuring China’s Technological Self-Reliance Drive - China …
Mar 1, 2023 Unsurprisingly, when it comes to China’s ambitious goals for promoting indigenous innovation (zizhu chuangxin) and technological self-reliance, Chinese policymakers have …See details»
Chuangxin - Crunchbase Company Profile & Funding
Chuangxin is a procurement solutions provider. They serve the semiconductor, energy, biomedical, automobile manufacturing, and robotics industries. The products involve various …See details»
WHO approval of Chinese CoronaVac COVID vaccine will be …
Jun 4, 2021 The World Health Organization (WHO) has approved a second Chinese vaccine for emergency use. CoronaVac was found to be 51% effective at preventing COVID-19 in late …See details»
China: USA, Canadian & European brands respond to risk of …
In October 2023, a collaboration between the New Yorker and the Outlaw Ocean project revealed evidence of human rights abuse within the Chinese seafood industry, including the use of …See details»
Sinopharm Capital - Crunchbase Investor Profile & Investments
Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, …See details»
China’s COVID vaccines are going global — but questions remain
May 4, 2021 The World Health Organization (WHO) has authorized the first of China’s COVID-19 vaccines for emergency use, and another could be listed in the coming days, opening the …See details»